Sobrepin

Sobrepin may be available in the countries listed below.

Ingredient matches for Sobrepin

Sobrerol

Sobrerol is reported as an ingredient of Sobrepin in the following countries:

• Italy


• Spain

International Drug Name Search

Peg-Intron

Ingredient matches for Peg Intron

Interferon alfa

Interferon alfa Interferon alfa-2b (Arg-23; His-34) (a derivative of Interferon alfa) is reported as an ingredient of Peg Intron in the following countries:

• Oman

Peginterferon Alfa 2-b

Peginterferon Alfa 2-b is reported as an ingredient of Peg Intron in the following countries:

• Chile


• Colombia


• Hong Kong


• Indonesia


• Taiwan


• United States

International Drug Name Search

Clindamicina Same

Clindamicina Same may be available in the countries listed below.

Ingredient matches for Clindamicina Same

Clindamycin

Clindamycin dihydrogen phosphate (a derivative of Clindamycin) is reported as an ingredient of Clindamicina Same in the following countries:

• Italy

International Drug Name Search

Doctors Foster and Smith Chlorhexidine Salve

Dosage Form: FOR ANIMAL USE ONLY
For Dogs, cats, and small pets

DIRECTIONS

Clean area thoroughly. Apply 1 to 3 times daily, to minor cuts, burns, and scrapes.

ACTIVE INGREDIENT

1.0% Chlorhexidine Diacetate

OTHER INGREDIENTS

Petrolatum, Boric Acid, Propylene CGlycol, Sucrose Octa Acetate, Fragrance, Vitamin A Palmtate, dl-Alpha Tocopheryl Acetate (source of Vitamin E), Cholecalciferol (source of Vitamin D3).

CAUTION

For external use only. Avoid contact with eyes. Consult your veterinarian in cases of deep or puncture wounds, animal bites, serious burns or if redness and irritation persists or increases.

STORAGE

Keep tightly closed at room temperature. Protect from freezing.

For animal use only

Keep out of reach of children and pets to avoid accidental ingestion

For Questions Or To Re-Order:

1-800-562-7169

Doctors

Foster and Smith           

Septi-Soothe

Salve

Veterinarian Formulated

Advanced Salve

Gentle, Antiseptic Formula

NET WT

0.85 OZ

(24 g)

DOCTORS FOSTER AND SMITH  chlorhexidine  salve

Product Information Product Type OTC ANIMAL DRUG NDC Product Code (Source) 65713-909 Route of Administration TOPICAL DEA Schedule

Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength CHLORHEXIDINE (CHLORHEXIDINE) CHLORHEXIDINE 0.24 g  in 24 g

Inactive Ingredients Ingredient Name Strength PETROLATUM   BORIC ACID   PROPYLENE GLYCOL   SUCROSE   VITAMIN A PALMITATE   ALPHA-TOCOPHEROL, DL-

Product Characteristics Color      Score      Shape Size Flavor Imprint Code Contains

Packaging # NDC Package Description Multilevel Packaging 1 65713-909-08 1 BOX In 1 BOX contains a TUBE (65713-909-09) 1 65713-909-09 24 g In 1 TUBE This package is contained within the BOX (65713-909-08)

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
unapproved drug other		01/01/2001

Labeler - Doctors Foster and Smith (122135148)

Registrant - United Pet Group (931135730)

Establishment
Name	Address	ID/FEI	Operations
JUNGLE LABORATORIES CORPORATION		032615270	manufacture

Revised: 03/2010Doctors Foster and Smith

Neosoralen

Neosoralen may be available in the countries listed below.

Ingredient matches for Neosoralen

Trioxysalen

Trioxysalen is reported as an ingredient of Neosoralen in the following countries:

• India

International Drug Name Search

Decatix

Decatix may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Decatix

Deltamethrin

Deltamethrin is reported as an ingredient of Decatix in the following countries:

• South Africa

International Drug Name Search

Raltegravir

Pronunciation: ral-TEG-ra-vir
Generic Name: Raltegravir
Brand Name: Isentress

Raltegravir is used for:

Treating certain patients who have HIV infection. It is used along with other HIV medicines.

Raltegravir is an HIV-1 integrase strand transfer inhibitor. It works by blocking HIV-1 integrase, an enzyme needed for the HIV virus to replicate.

Do NOT use Raltegravir if:

• you are allergic to any ingredient in Raltegravir

Contact your doctor or health care provider right away if any of these apply to you.

Before using Raltegravir:

Some medical conditions may interact with Raltegravir. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substance


• if you have a history of liver problems or hepatitis B or C infection


• if you have a history of muscle problems or weakness (eg, myopathy, rhabdomyolysis), mental or mood problems (eg, depression), or suicidal thoughts or attempts


• if you are on dialysis

Some MEDICINES MAY INTERACT with Raltegravir. Tell your health care provider if you are taking any other medicines, especially any of the following:

• HMG-CoA reductase inhibitors (eg, simvastatin) because the risk of muscle problems may be increased


• Darunavir because it may increase the risk of rash


• Medicines that may harm the liver (eg, acetaminophen, methotrexate, ketoconazole, isoniazid, certain medicines for HIV infection) because the risk of liver side effects may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver


• Phenobarbital, phenytoin, or rifamycins (eg, rifampin) because they may decrease Raltegravir's effectiveness

This may not be a complete list of all interactions that may occur. Ask your health care provider if Raltegravir may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Raltegravir:

Use Raltegravir as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• An extra patient leaflet is available with Raltegravir. Talk to your pharmacist if you have questions about this information.


• Take Raltegravir by mouth with or without food.


• Take Raltegravir on a regular schedule to get the most benefit from it. Taking Raltegravir at the same time each day will help you remember to take it.


• Continue to take Raltegravir even if you feel well. Do not miss any doses.


• If you miss a dose of Raltegravir, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Raltegravir.

Important safety information:

• Raltegravir may cause dizziness. This effect may be worse if you take it with alcohol or certain medicines. Use Raltegravir with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Raltegravir may improve immune system function. This may reveal hidden infections in some patients. Tell your doctor right away if you notice symptoms of infection (eg, fever, sore throat, weakness, cough, shortness of breath) after you start Raltegravir.


• Raltegravir is not a cure for HIV infection. Patients may still get illnesses and infections associated with HIV. Remain under the care of your doctor.


• Do not change your dose or stop taking Raltegravir or any other medicine for HIV without checking with your doctor.


• When your medicine supply is low, get more from your doctor or pharmacist as soon as you can. Do not stop taking Raltegravir, even for a short period of time. If you do, the virus may grow resistant to the medicine and become harder to treat.


• Raltegravir does not stop the spread of HIV to others through blood or sexual contact. Use barrier methods of birth control (eg, condoms) if you have HIV infection. Do not share needles, injection supplies, or items like toothbrushes or razors.


• Lab tests, including complete blood cell counts and liver function, may be performed while you take Raltegravir. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.


• Raltegravir should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of taking Raltegravir while you are pregnant. It is not known if Raltegravir is found in breast milk. Mothers infected with HIV should not breast-feed. There is a risk of passing the HIV infection or Raltegravir to the baby.

Possible side effects of Raltegravir:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Diarrhea; dizziness; headache; nausea; tiredness; trouble sleeping; weakness.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); change in the amount of urine produced; clumsiness; decreased coordination; eye inflammation; fever, chills, or sore throat; general feeling of being unwell; joint aches; mental or mood changes (eg, anxiety, paranoia, depression); mouth sores; muscle aches, pain, tenderness, or weakness; red, swollen, blistered, or peeling skin; severe or persistent dizziness; severe or persistent tiredness or weakness; shortness of breath; suicidal thoughts or actions; symptoms of liver problems (eg, dark urine, loss of appetite, pale stools, severe or persistent nausea or vomiting, stomach pain, yellowing of the skin or eyes); unusual bruising or bleeding.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Raltegravir side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately.

Proper storage of Raltegravir:

Store Raltegravir at room temperature, between 68 and 77 degrees F (20 and 25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Raltegravir out of the reach of children and away from pets.

General information:

• If you have any questions about Raltegravir, please talk with your doctor, pharmacist, or other health care provider.


• Raltegravir is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Raltegravir. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Raltegravir resources

• Raltegravir Side Effects (in more detail)
• Raltegravir Use in Pregnancy & Breastfeeding
• Raltegravir Drug Interactions
• Raltegravir Support Group
• 5 Reviews for Raltegravir - Add your own review/rating

• Raltegravir Professional Patient Advice (Wolters Kluwer)


• raltegravir Advanced Consumer (Micromedex) - Includes Dosage Information


• Isentress Prescribing Information (FDA)


• Isentress Monograph (AHFS DI)


• Isentress Consumer Overview

Compare Raltegravir with other medications

• HIV Infection

Once a Day Cephalexin

Once a Day Cephalexin may be available in the countries listed below.

In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Once a Day Cephalexin

Cefalexin

Cefalexin monohydrate (a derivative of Cefalexin) is reported as an ingredient of Once a Day Cephalexin in the following countries:

• Australia

International Drug Name Search

Calamiraderon

Calamiraderon may be available in the countries listed below.

Ingredient matches for Calamiraderon

Betamethasone

Betamethasone 17α-valerate (a derivative of Betamethasone) is reported as an ingredient of Calamiraderon in the following countries:

• Japan

International Drug Name Search

Kefungin

Kefungin may be available in the countries listed below.

Ingredient matches for Kefungin

Ketoconazole

Ketoconazole is reported as an ingredient of Kefungin in the following countries:

• Romania

International Drug Name Search

Kimotab S

Kimotab S may be available in the countries listed below.

Ingredient matches for Kimotab S

Bromelains

Bromelains is reported as an ingredient of Kimotab S in the following countries:

• Japan

International Drug Name Search

Kaligon

Kaligon may be available in the countries listed below.

Ingredient matches for Kaligon

Potassium Gluconate

Potassium Gluconate is reported as an ingredient of Kaligon in the following countries:

• Algeria

International Drug Name Search

Diclovat

Diclovat may be available in the countries listed below.

Ingredient matches for Diclovat

Diclofenac

Diclofenac sodium salt (a derivative of Diclofenac) is reported as an ingredient of Diclovat in the following countries:

• Vietnam

International Drug Name Search

Kanamycin Meiji

Kanamycin Meiji may be available in the countries listed below.

Ingredient matches for Kanamycin Meiji

Kanamycin

Kanamycin sulfate (a derivative of Kanamycin) is reported as an ingredient of Kanamycin Meiji in the following countries:

• Hong Kong


• Taiwan

International Drug Name Search